Our team at Creative Ventures invests in technologies that address the inexorable rise in healthcare costs globally. These costs are driven by the secular demographic trend of aging populations and rising chronic disease—and without innovations within healthcare, will force us to face a grim tradeoff of either consuming all of our economic output in maintaining an aging population or being forced to more severely ration care.
That all being said, healthcare is complex with many different stakeholders. Even though this tailwind means that the industry will continue to grow rapidly over this decade and beyond, adoption of technologies requires aligning a complicated web of providers (hospitals), clinicians, payers, and regulators. All of this requires clearly understanding the sociopolitical landscape of healthcare, along with the economic driver of chronic/metabolic disease making our global population sicker and harder to care for.
Back in April, we said It’s a Good time to Invest in Healthcare Diagnostics.
Companies that fit well into the healthcare diagnostics market, satisfy a unique need not already addressed, and have clear pathways to regulatory approval are the ones to watch out for.
Click here to learn the different fields of healthcare diagnostics, innovation in diagnostic technology you should be watching, why Creative Ventures chooses to invest, and how we systematically invest in the space.
- Kidney Disease: A Sadly (and Costly) Killer: Creative Ventures led an investment into VenoStent, an advanced-material technology company working on eliminating the 50%+ failure rate in vascular-access surgery required to initiate hemodialysis. Here we unravel the underlying macrotrends driving the development of solutions and investment opportunities in this sector.
The pandemic catapulted the world into tech-based healthcare.
The increased demand on the healthcare system triggered many healthcare organizations to make changes to their delivery systems. Hospitals and clinics used telemedicine and remote patient monitoring services to provide meaningful solutions and supplement some healthcare delivery and services deficiencies.
Still, digital health is more nuanced than other sectors, and scaling presents a challenge. See our thoughts on the subject here.
- The Business of Healthcare: Healthcare innovation is a graveyard of failed companies with a lot of potential to save lives and improve quality of care. If you want to actually succeed and realize that potential, you need to think far more about the economic incentives and flow of money related to your product.